Radium-223 dichloride
Name: Radium-223 dichloride
Adverse Effects
>10%
Percentages includes all toxicity grades (1-4)
Anemia (93%)
Lymphocytopenia (72%)
Leukopenia (35%)
Thrombocytopenia (31%)
Nausea (36%)
Diarrhea (25%)
Vomiting (19%)
Neutropenia (18%)
Peripheral edema (13%)
1-10%
Percentages includes all toxicity grades (1-4)
Renal failure and impairment (3%)
Dehydration (3%)
Pancytopenia (2%)
Erythema, pain, and edema at injection site (1%)
Pregnancy & Lactation
Pregnancy Category: X
Lactation: Not indicated for women; unknown if distributed in human breast milk
Pregnancy Categories
A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA:Information not available.